An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Drug Gaining Traction Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these profiles directly for source information, while also receiving promotional offers.
Active Commerce on Social Networks
Additionally, a flourishing market exists on messaging services, where communities with numerous of participants share comparison images, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Experts Express Concerns
Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.
Several professionals said the demand for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.
Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Elimination
Based on the social media company, the service has removed problematic content and prohibited associated hashtags and search suggestions. The organization said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found groups with up to nine thousand participants selling retatrutide using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, populated with photos of weight loss, glowing reviews and detailed guides for preparing or injecting at residence.
Within moments of joining one community, a vendor posted WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.
Item Details and Pricing
Inside these communities, posts show black plastic packages with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how much time a injector should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram said it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering substances they can’t verify. Even if the research behind this drug is valid, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to potentially serious medical dangers”.
